Welcome to Lawsuit.com  

Our mission is to provide each client with the most effective ethical representation possible, and to preserve and promote the civil justice system.

Warning on Exjade and Liver Failure

Posted on April 29, 2008

Novartis is warning healthcare professionals that hepatic failure can occur in patients treated with Exjade(deferasirox). Exjade is used to treat tranfusional hemosiderosis, the chronic iron overload that can result from multiple blood transfusions.

Cases of liver failure, some of them fatal, have been reported in patients treated with Exjade. Most of these cases occurred in patients over 55 years old who had significant comorbidities, including liver cirrhosis and multi-organ failure.

Because of this, liver function should be monitored monthly, and if there is unexplained, persistent, or progressive increase in serum transaminase levels, Exjade treatment should be modified or interrupted.

Additional Information:

FDA MedWatch Safety Alert. Exjade (deferasirox) Tablets For Oral Suspension. December 13, 2007.
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Exjade

Lawsuit Membership
Law firms interested in becoming part of this unique legal community should apply here.Join Lawsuit.com

Lawsuit Video Tips
To become a participating member of Lawsuit.com you must supply a video about your firm, talk about the litigation you find important, and how you help your clients. For ideas and video tips on effective videos click here. Video Creation Tips

Become an Editor
Lawsuit.com is currently building one of the largest human-edited legal video databases in the Web 2.0 World. Want to help? Apply here to become an Editor.Comment